Page last updated: 2024-09-04

rp 73401 and tetradecanoylphorbol acetate

rp 73401 has been researched along with tetradecanoylphorbol acetate in 1 studies

Compound Research Comparison

Studies
(rp 73401)
Trials
(rp 73401)
Recent Studies (post-2010)
(rp 73401)
Studies
(tetradecanoylphorbol acetate)
Trials
(tetradecanoylphorbol acetate)
Recent Studies (post-2010) (tetradecanoylphorbol acetate)
9202331,050612,217

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baik, KU; Cho, JY; Kim, HP; Lee, JG; Park, JS; Park, MH; Yoo, ES1

Other Studies

1 other study(ies) available for rp 73401 and tetradecanoylphorbol acetate

ArticleYear
Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevent to rheumatoid arthritis.
    Pharmacological research, 2004, Volume: 49, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arachidonic Acid; Arthritis, Experimental; Arthritis, Rheumatoid; Benzamides; Cell Physiological Phenomena; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Drug Evaluation, Preclinical; Ear Diseases; Edema; Humans; Immunity, Active; Inflammation; Lipopolysaccharides; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Nitric Oxide; Pyridines; Rats; Rats, Sprague-Dawley; Spleen; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; U937 Cells

2004